Patrick Lin
CIK: 0001799363
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Processa Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
8.5K shares- - Jun 30, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct2.1K shares at avg. $1.93$4K - Jun 15, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct1.8K shares at avg. $2.22$4K - May 29, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct1.6K shares at avg. $2.57$4K - May 15, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct1.4K shares at avg. $2.97$4K - Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct1.5K shares at avg. $2.69$4K - Apr 15, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct1.4K shares at avg. $2.97$4K - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct1.6K shares at avg. $2.54$4K - Jan 1, 2026PCSA
Processa Pharmaceuticals, Inc.
Exercise(M)Direct193 shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectStock Options (Right to Buy)
204K shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
68K shares- - Jul 24, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
1.4M shares- - Apr 1, 2025PCSA
Processa Pharmaceuticals, Inc.
Tax Payment(F)Direct4.8K shares at avg. $0.41$2K - Apr 1, 2025PCSA
Processa Pharmaceuticals, Inc.
Exercise(M)Direct14.5K shares- - Jan 29, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)IndirectWarrants
43.5K shares- - Jan 29, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)IndirectWarrants
21.8K shares- - Jan 27, 2025PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Indirect43.5K shares at avg. $0.80$35K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 8,450 | - | - | Direct |
| Jun 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 2,106 | $1.93 | $4,065 | Direct |
| Jun 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 1,831 | $2.22 | $4,065 | Direct |
| May 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 1,582 | $2.57 | $4,066 | Direct |
| May 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 1,369 | $2.97 | $4,066 | Direct |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 1,511 | $2.69 | $4,065 | Direct |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 1,369 | $2.97 | $4,066 | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 1,603 | $2.54 | $4,064 | Direct |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | Exercise(M) | 193 | - | $0 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Stock Options (Right to Buy) | 204,000 | - | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 68,000 | - | - | Direct |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 1,401,650 | - | - | Direct |
| Apr 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Tax Payment(F) | 4,814 | $0.41 | $1,983 | Direct |
| Apr 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Exercise(M) | 14,482 | - | - | Direct |
| Jan 29, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Warrants | 43,500 | - | - | Indirect |
| Jan 29, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Warrants | 21,750 | - | - | Indirect |
| Jan 27, 2025 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 43,500 | $0.80 | $34,691 | Indirect |
1-17 of 17 transactions
About Lin Patrick
Lin Patrick (SEC CIK 0001799363) files insider reports with the SEC as Chief Business - Strategy Off of Processa Pharmaceuticals, Inc. (PCSA).
Signal8 holds 15 ownership filings by Lin Patrick, all Form 4s, filed between Jan 29, 2025 and Jul 28, 2026. Those filings report 17 transactions, from Jan 27, 2025 to Jul 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lin Patrick's filings is in VERO BEACH, FL.
Recent filings by Lin Patrick
- Jul 26, 2026: Grant or award of PCSA derivative securities (Form 4, code A).
- Jun 30, 2026: Open-market purchase of PCSA shares (Form 4, code P).
- Jun 15, 2026: Open-market purchase of PCSA shares (Form 4, code P).
- May 29, 2026: Open-market purchase of PCSA shares (Form 4, code P).
- May 15, 2026: Open-market purchase of PCSA shares (Form 4, code P).
Other insiders filing for Processa Pharmaceuticals, Inc. (PCSA)
- Ng George K, Chief Executive Officer
- GUJRATHI SHEILA, Director
- Yorke Justin W, Director
- SKIBSTED RUSSELL, Chief Financial Officer
- Pannu Geraldine, Director
- Neal James R, Director